Innovus Pharmaceuticals, Inc. INNV 深 滬
等待開盤 09-23 09:30:00 美东时间
10.655
+0.055
+0.52%
華盛通- 最 高10.8099
- 今 開10.63
- 成交量 28.99万股
- 最 低 10.45
- 昨 收 10.60
- 總市值 14.54亿
- 52周最高 12.64
- 市盈率 靜 --
- 換手率 0.21%
- 52周最低 3.935
- 委 比 -45.21%
- 總股本 1.36亿
- 歷史最高 27.18
- 量 比 1.18
- 振 幅 3.40%
- 歷史最低 2.60
- 每 手 1
- 風險率 2.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多InnovAge announces 10M share secondary offering
InnovAge Holding (INNV) said on Tuesday Apax Partners- and Welsh Carson-affiliated funds are offering 10M existing shares in a secondary offering. The selling stockholders may grant underwriters a 30-...
今天 04:11
UPDATED: InnovAge Announces 10M Share Public Secondary Offering By Selling Stockholders
InnovAge Holding Corp. (“InnovAge” or the “Company”) (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the launch of an underwritten public ...
今天 04:04
InnovAge Holding Corp. Signals Breakout Year in Earnings
Innovage Holding Corp. (($INNV)) has held its Q4 earnings call. Read on for the...
09-16 08:31
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
Keybanc Maintains Overweight on InnovAge Holding, Raises Price Target to $14
Keybanc analyst Matthew Gillmor maintains InnovAge Holding (NASDAQ:INNV) with a Overweight and raises the price target from $13 to $14.
09-09 20:42
InnovAge Holding (INNV) Stock Jumps Over 10% After-Hours: Why is it Moving?
InnovAge Holding Corp. (NASDAQ:INNV) shares climbed 10.25% to $11.60 in after-hours trading on Tuesday after the company announced fourth-quarter results, where revenue of $261.95 million surpassed the analyst estimate of $238.28 million by 9.93%. The Denver-based senior healthcare provider announce...
09-09 16:05
InnovAge Holding Sees FY2027 Sales $1.050B-$1.085B vs $1.038B Est
InnovAge Holding (NASDAQ:INNV) sees FY2027 sales of $1.050 billion-$1.085 billion vs $1.038 billion analyst estimate.
09-09 04:08
InnovAge Holding Q4 EPS $0.06 Misses $0.07 Estimate, Sales $261.951M Beat $238.267M Estimate
InnovAge Holding (NASDAQ:INNV) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.07 by 14.29 percent. This is a 700 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $261.951 millio...
09-09 04:05
美股大行评级 | 罗斯百货、迪尔股份获多家大行上调目标价；沃尔玛、Advance遭多家大行下调目标价
今日重点评级关注：摩根士丹利：维持Ultragenyx Pharmaceutical"超配"评级，目标价从67美元升至74美元；Truist Securities：维持Solid Biosciences"买入"评级，目标价从16美元升至20美元
08-24 16:40
Keybanc Upgrades InnovAge Holding to Overweight, Announces $13 Price Target
Keybanc analyst Matthew Gillmor upgrades InnovAge Holding (NASDAQ:INNV) from Sector Weight to Overweight and announces $13 price target.
08-21 17:59
